119 related articles for article (PubMed ID: 37976824)
1. Exploring the utility of FTS as a bonafide binding partner for EGFR: A potential drug target for cervical cancer.
Krishnamoorthy S; Muruganantham B; Yu JR; Park WY; Muthusami S
Comput Biol Med; 2023 Dec; 167():107592. PubMed ID: 37976824
[TBL] [Abstract][Full Text] [Related]
2. Silencing of fused toes homolog enhances cisplatin sensitivity in cervical cancer cells by inhibiting epidermal growth factor receptor-mediated repair of DNA damage.
Subramanian PD; An Z; Yu JR; Park WY
Cancer Chemother Pharmacol; 2016 Oct; 78(4):753-62. PubMed ID: 27535835
[TBL] [Abstract][Full Text] [Related]
3. FTS is responsible for radiation-induced nuclear phosphorylation of EGFR and repair of DNA damage in cervical cancer cells.
Muthusami S; Prabakaran DS; Yu JR; Park WY
J Cancer Res Clin Oncol; 2015 Feb; 141(2):203-10. PubMed ID: 25151576
[TBL] [Abstract][Full Text] [Related]
4. EGF-induced expression of Fused Toes Homolog (FTS) facilitates epithelial-mesenchymal transition and promotes cell migration in ME180 cervical cancer cells.
Muthusami S; Prabakaran DS; Yu JR; Park WY
Cancer Lett; 2014 Sep; 351(2):252-9. PubMed ID: 24971934
[TBL] [Abstract][Full Text] [Related]
5. MiR-33a Controls hMSCS Osteoblast Commitment Modulating the Yap/Taz Expression Through EGFR Signaling Regulation.
Costa V; Carina V; Raimondi L; De Luca A; Bellavia D; Conigliaro A; Salamanna F; Alessandro R; Fini M; Giavaresi G
Cells; 2019 Nov; 8(12):. PubMed ID: 31771093
[TBL] [Abstract][Full Text] [Related]
6. A review on the role of epidermal growth factor signaling in the development, progression and treatment of cervical cancer.
Muthusami S; Sabanayagam R; Periyasamy L; Muruganantham B; Park WY
Int J Biol Macromol; 2022 Jan; 194():179-187. PubMed ID: 34848237
[TBL] [Abstract][Full Text] [Related]
7. EGCG suppresses Fused Toes Homolog protein through p53 in cervical cancer cells.
Muthusami S; Prabakaran DS; An Z; Yu JR; Park WY
Mol Biol Rep; 2013 Oct; 40(10):5587-96. PubMed ID: 24065519
[TBL] [Abstract][Full Text] [Related]
8. FTS (fused toes homolog) a novel oncoprotein involved in uterine cervical carcinogenesis and a potential diagnostic marker for cervical cancer.
Cinghu S; Anandharaj A; Lee HC; Yu JR; Park WY
J Cell Physiol; 2011 Jun; 226(6):1564-72. PubMed ID: 20945372
[TBL] [Abstract][Full Text] [Related]
9. CircMYBL2 regulates the resistance of cervical cancer cells to paclitaxel via miR-665-dependent regulation of EGFR.
Dong M; Li P; Xie Y; Wang Z; Wang R
Drug Dev Res; 2021 Dec; 82(8):1193-1205. PubMed ID: 34046939
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
11. Silencing of FTS increases radiosensitivity by blocking radiation-induced Notch1 activation and spheroid formation in cervical cancer cells.
Prabakaran DS; Muthusami S; Sivaraman T; Yu JR; Park WY
Int J Biol Macromol; 2019 Apr; 126():1318-1325. PubMed ID: 30244128
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis of Novel Targets for Treating Cervical Cancer by Immunotherapy Based on Immune Escape.
Han YH; Ma DY; Lee SJ; Mao YY; Sun SY; Jin MH; Sun HN; Kwon T
Cancer Genomics Proteomics; 2023; 20(4):383-397. PubMed ID: 37400149
[TBL] [Abstract][Full Text] [Related]
13. H3K27ac-activated EGFR-AS1 promotes cell growth in cervical cancer through ACTN4-mediated WNT pathway.
Li J; Wang H
Biol Direct; 2022 Jan; 17(1):3. PubMed ID: 34998421
[TBL] [Abstract][Full Text] [Related]
14. Role of microRNAs in epidermal growth factor receptor signaling pathway in cervical cancer.
Hemmat N; Mokhtarzadeh A; Aghazadeh M; Jadidi-Niaragh F; Baradaran B; Bannazadeh Baghi H
Mol Biol Rep; 2020 Jun; 47(6):4553-4568. PubMed ID: 32383136
[TBL] [Abstract][Full Text] [Related]
15. A comparative analysis of phyto-components on EGFR binding, viability, and migration in HPV positive ME180 and HPV negative C33A cervical cancer cells.
Sabanayagam R; Krishnamoorthy S; Anbuselvam M; Muruganantham B; Muthusami S
Med Oncol; 2023 Nov; 40(12):357. PubMed ID: 37964051
[TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
Yang W; Xie T
Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the Role and Regulatory Mechanism of hsa-miR-504 in Cervical Cancer Based on The Cancer Genome Atlas Database.
Li D; Liu SH; Liu QY; Zou QQ; Lv L; Liu GL; Wu Y
Cancer Biother Radiopharm; 2021 Aug; 36(6):511-520. PubMed ID: 32589477
[No Abstract] [Full Text] [Related]
18. Human Cytomegalovirus miR-US5-2 Downregulation of GAB1 Regulates Cellular Proliferation and
Hancock MH; Mitchell J; Goodrum FD; Nelson JA
mSphere; 2020 Aug; 5(4):. PubMed ID: 32759334
[TBL] [Abstract][Full Text] [Related]
19. Fused Toes Homolog modulates radiation cytotoxicity in uterine cervical cancer cells.
Anandharaj A; Cinghu S; Kim WD; Yu JR; Park WY
Mol Biol Rep; 2011 Nov; 38(8):5361-70. PubMed ID: 21424602
[TBL] [Abstract][Full Text] [Related]
20. Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer.
D S P; Chaturvedi PK; Krishnamoorthy D; Seo YS; Thippana M; Park WY
PLoS One; 2022; 17(4):e0266532. PubMed ID: 35421154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
